Halozyme Therapeutics

HALO

HALO
Halozyme Therapeutics Stock Quote
$15.34 $0.08 0.6%
BATS BZX Real Time Price as of October 21, 2019, 4:00 p.m. EDT View Interactive HALO Charts

A biopharmaceutical company dedicated to the development and commercialization of recombinant human enzymes for the drug delivery, palliative care, oncology and infertility markets.

News & Analysis: Halozyme Therapeutics

The Fool has written over 100 articles on Halozyme Therapeutics.

All

Market Moves

Earnings








3 Monster Stocks in the Making

Halozyme Therapeutics, FMC Corp., and Braskem all have major opportunities in front of them that could lead to outsize returns.




Interactive Chart